The Alzheimer amyloid precursor protein (APP) is a transmembrane protein whose abnormal processing is associated with the pathogenesis of Alzheimer's disease. Activated caspases cleave APP and generate its carboxylterminally truncated fragment (APPDC31). We have previously reported that overexpression of wild-type APP induces caspase-3 activation and apoptosis in postmitotic neurons. We now report that APPDC31 potentially plays pathophysiological roles in neuronal death. Adenovirus-mediated overexpression of wild-type APP695 induced activation of caspase-3 and accumulation of APPDC31 in postmitotic neurons derived from human NT2 embryonal carcinoma cells, whereas an APP mutant lacking the Ab(1 ± 20) region induced neither caspase-3 activation nor APPDC31 generation. Inhibition of caspase-3 suppressed the generation of APPDC31 in APP-overexpressing neurons. Forced expression of APPDC31 induced apoptotic changes of neurons and non-neuronal cells, but failed to activate caspase-3. The cytotoxicity of APPDC31 was also dependent on the Ab(1 ± 20) region. These results suggest that accumulation of wild-type APP activates neuronal caspase-3 to generate APPDC31 that mediates caspase-3-independent cell death.
Introduction
Alzheimer's disease (AD) is a neurodegenerative disease characterized by massive amounts of neuronal death associated with histopathological hallmarks such as extracellular deposition of amyloid fibrils and intracellular accumulation of neurofibrillary tangles. The principal constituent of the amyloid fibrils is b/A4 (Ab) 1 which is generated by processing of the amyloid precursor protein (APP). APP and Ab have been considered as key molecules involved in the pathogenesis of AD. 2 ± 5 APP695, an APP isoform lacking the protease inhibitor domain, is abundantly expressed in postmitotic neurons during early periods of their differentiation. 6 However, physiological and pathological roles of APP in neurons remain largely unknown. Earlier studies using APPdeficient cells suggest that cell-associated APP enhances neuronal survival and exerts neuroprotective functions. 7, 8 In contrast, we have previously reported that overexpression of wild-type APP695 induced death of postmitotic neurons derived from murine embryonal carcinoma P19 cells. 6 Furthermore, viral vector-mediated overexpression of wildtype APP induces apoptosis-like death of postmitotic neurons both in vivo and in vitro. 9 ± 12 In APP-accumulating neurons in vitro, caspase-3 is activated in a cleavagedependent manner, and a caspase-3 inhibitor significantly reduces the severity of degeneration exhibited by APPoverexpressing neurons. 11 These observations suggest that unphysiological levels of wild-type APP induce neuronal apoptosis in a caspase-dependent manner.
Caspases have a regulatory role in programmed death of chick spinal motoneurons, 13 in which APP expression is upregulated during the course of cell death.
14 Neurodegenerative insults induce cytoplasmic cleavage of endogenous APP by caspases and generate an APP fragment that lacks the carboxyl (C)-terminal 31-residue region (APPDC31). 15 Caspase-6, which is activated in apoptotic neurons under serum-deprived conditions, cleaves APP directly at the cytoplasmic domain and generates Abcontaining fragments. 16 These findings suggest a close link between APP and the caspase-mediated death machinery.
In this study, we demonstrate that APPDC31 per se exerts cytotoxic effects on human postmitotic neurons and its precursor stem cells. Immunocytochemistry using endspecific antibodies against caspase-cleaved APP fragments revealed that wild-type APP undergoes proteolytic processing into APPDC31 and APP665±695 (APP-C31) when overexpressed in postmitotic neurons. We also show that APPDC31 induces nuclear changes indicative of apoptosis in postmitotic neurons and non-neuronal cells but fails to activate caspase-3. These findings raise the possibility that this caspase-cleaved form of APP has its own role in the modulation of neuronal death.
Results

Activation of caspase-3 and generation of APPDC31 in neurons by serum deprivation
We raised end-specific antibodies against activated caspase-3 subunits (ACP3) and the C-terminus of APPDC31 (SAC) to detect intraneuronal caspase-3 activation and APPDC31 generation. It has been reported that neurodegenerative insults activate neuronal caspases that cleave endogenous APP into APPDC31. 15 We used postmitotic neurons under serum-deprived conditions to test the specificities and sensitivities of these antibodies ( Figure 1 ). Differentiated neurons, which were identified by staining for the neuronal marker microtubule-associated protein 2 (MAP2), showed apoptotic features such as nuclear fragmentation and condensation by serum deprivation for 96 h. Immunocytochemistry using these antibodies revealed that these apoptotic neurons contained both activated caspase-3 and APPDC31. In contrast, MAP2-positive neurons had neither activated caspase-3 nor APPDC31 under serum-supplemented conditions. These data suggest that neuronal caspases are activated by serum-deprivation and cleave endogenous APP at the cytoplasmic domain, and that the endspecific antibodies ACP3 and SAC properly recognize activated caspase-3 subunits and the C-terminus of APPDC31, respectively.
Neuronal caspase-3-activation by accumulation of wild-type APP is dependent on the Ab domain
We infected recombinant adenoviruses expressing wild-type APP and its mutant lacking the Ab(1 ± 20) region (APPDAb20) into neurally differentiated NT2 neurons (Figure 2A ). APPaccumulating neurons had condensed, fragmented nuclei and active caspase-3 subunits 48 h after infection, whereas a few neurons overexpressing APPDAb20 or b-galactosidase (bGal) were positively stained for activated caspase-3. Quantification of caspase-3-immunopositive neurons revealed that 40% of neurons accumulating wild-type APP contained activated caspase-3 at 48 h ( Figure 2B ). Under these conditions, the population of caspase-3-immunopositive neurons among APPDAb20-accumulating neurons was similar to that of b-Gal-accumulating neurons (*10%). When dead neurons were quantified using ethidium homodimer-1 (EthD-1), a fluorescent dye excluded by viable cells, 36% of neurons accumulating wild-type APP were found to be dead at 72 h ( Figure 2C ). In contrast, the population of dead neurons among APPDAb20-accumulating neurons was *6%, a level similar to that of b-Gal-accumulating neurons. These results suggest that the Ab(1 ± 20) region of APP is required for activation of neuronal caspase-3.
Cleavage of APP at the cytoplasmic site in neurons overexpressing wild-type APP Because the cytoplasmic region of wild-type APP695 contains the caspase cleavage site (VEVD), overexpressed full-length APP can be cleaved by caspases into the 664-residue amino (N)-terminal fragment (APPDC31) and the 31-residue Cterminal fragment (APP-C31). Using antibodies against the Cterminal end of APPDC31 (SAC) and the N-terminal end of APP-C31 (ACT1), we examined whether APPDC31 and APP-C31 are actually generated in postmitotic neurons overexpressing wild-type APP. APP-overexpressing NT2 neurons were stained for the N-terminus of APP with antibody P2-1 and chromosomal DNA with Hoechst 33342 ( Figure 3A) . Most of wild-type APP-accumulating neurons had shrunken and fragmented nuclei. These apoptotic neurons were immunopositive for both APPDC31 and APP-C31 at 72 h as judged by staining with SAC and ACT1, respectively. In contrast, APPDC31 and APP-C31 were hardly detected in APPDAb20-accumulating neurons or APP-accumulating nonneuronal cells in the mixed cultures.
To examine whether caspase-3 is involved in the cleavage of APP at the cytoplasmic site, we treated APPoverexpressing neurons with the cell permeable caspase-3 inhibitor carbobenzoxy-Asp-Glu-Val-Asp-fluoromethylketone (Z-DEVD-FMK) and examined the generation of APPDC31 and APP-C31 with the end-specific antibodies SAC and ACT1 ( Figure 3B ). In the absence of the inhibitor, 44% and 29% of APP-accumulating neurons were found to be immunopositive for SAC and ACT1 immunoreactivities, respectively. In the presence of the inhibitor (150 mM), the proportions of APPDC31-and APP-C31-accumulating neurons were significantly decreased to 18% and 13%, respectively. The inhibitor had no appreciable effects on the proportions of SAC-and ACT1-immunopositive neurons that overexpressed APPDAb20. These results suggest that activated caspase-3 caused by intracellular accumulation Western blot analysis revealed that wild-type APP and mutant proteins were abundantly expressed as analyzed using antibodies against the C-terminus of APP (AC1) ( Figure 4A ) and the N-terminus (AN2) ( Figure 4B , upper panel). Neurons overexpressing wild-type APP contained a 96 kDa SAC-immunoreactive fragment, which was detected in APPDC31-overexpressing neurons ( Figure 4B , lower panel). The amount of APPDC31 in neurons overexpressing wild-type APP was similar to that in neurons overexpressing APPDC31, suggesting that a considerable amount of wildtype APP is processed into APPDC31. In contrast, APPDC31 was undetected in neurons overexpressing APPDAb20 or b-Gal. These results, together with the data shown in Figures 2 and 3 , suggest that overexpression of wild-type APP activates neuronal caspases that eventually cleave APP at the cytoplasmic site.
We have previously shown that a C-terminal 100 amino acid fragment of APP (APP-C100), which encompasses the Ab domain and the C31 region, forms amyloid fibril-like structures in cDNA-transfected COS cells. 17 We then examined whether full-length APP self-associates when accumulated on the membrane. Cell surface proteins in NT2 neurons infected with recombinant adenoviruses expressing b-Gal, wild-type APP, APPDAb20 and APPDC31 were treated with a membrane-impermeable cross-linker and analyzed by Western blotting using the antibody against the N-terminus of APP (AN2) ( Figure 4C ). APP immunoreactive bands were detected at *110 kDa and 4220 kDa. The 4220 kDa bands, which may correspond to APP cross-linked with other membrane proteins, were undetected in the absence of the crosslinker (data not shown). Only the neurons overexpressing wild-type APP contained a distinct *220 kDa APP immunoreactive band, whose size corresponds to that of the APP homodimer. These results suggest that the transmembrane form of APP tend to self-associate when concentrated on the membrane.
Caspase-3-independent neuronal death induced by APPDC31
Because APPDC31 was generated in neurons overexpressing wild-type APP, we then examined whether APPDC31 per se affects neuronal viability. We constructed the adenovirus vector expressing APPDC31 (AxCAPDC31) and infected it into NT2 neurons ( Figure 5 ). A number of APPDC31-expressing neurons underwent death as analyzed by EthD-1 retention test (top panels). These degenerated neurons had nuclei stained positively by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) (middle panels). Intriguingly, APPDC31-accumulating neurons carrying apoptotic nuclei contained little or no activated caspase-3-immunoreactivity (bottom panels). These results suggest that APPDC31 induces neuronal apoptosis in a caspase-3-independent manner. Quantification of neuron death by the EthD-1 retention assay revealed that 28% of APPDC31-expressing neurons were dead. Under the same conditions, b-Gal and wildtype APP caused neuron death at 7% and 33%, respectively ( Figure 6A ). We then measured caspase-3-like protease activity in neurons overexpressing wild-type APP, APPDC31, APPDAb20, or b-Gal using the fluorogenic substrate carbobenzoxy-Asp-Glu-Val-Asp-7-amino-4-trifluoromethyl coumarin (Z-DEVD-AFC) ( Figure 6B ). In agreement with the immunocytochemical data shown in Figures 2A and 5 , caspase-3-like activities in APPDC31, APPDAb20, and b-Gal-overexpressing neurons remained low during the 96-h incubation period, whereas the activity in wild-type APP-overexpressing neurons increased and reached a peak at 48 h.
Cytotoxicity of APPDC31 is not specific to postmitotic neurons
We have previously shown that caspase-3-mediated apoptosis by wild-type APP is specific to postmitotic neurons. 11 The present study has shown that APPDC31 induced caspase-3-independent neuronal death. These findings suggested that APPDC31 induces apoptosis in a manner distinct from that of wild-type APP. When NT2 embryonal carcinoma stem cells (NT2S) and differentiated neurons (NT2N) were infected with the adenovirus vector expressing APPDC31, some of the stem cells and neurons showed apoptotic changes and EthD-1 retention (Figure 7 ). In contrast, most of the stem cells overexpressing wild-type APP were morphologically intact and showed little or no EthD-1 retention.
We then quantified the cytotoxic effects of b-Gal, APPDC31, wild-type APP, and APPDAb20 on NT2 stem cells and transformed cell lines ( Figure 8A ). Only APPDC31 caused a significant increase in the dead population of nonneuronal cells such as NT2 stem cells, African green monkey kidney COS-1 cells, human glioma Bu17 cells, and human cervical carcinoma HeLa cells. The cytotoxic effects of wild-type APP and APPDAb20 were hardly detected in these non-neuronal cells as compared with the values of the negative control of b-Gal (P40.05). In contrast, the cytotoxic effect of wild-type APP was seen only in NT2 neurons. These results indicate that APPDC31, unlike wildtype APP, is cytotoxic to non-neuronal cells as well as to postmitotic neurons. In order to examine whether the Ab(1 ± 20) domain in APPDC31 is responsible for its cytotoxicity, we constructed a vector expressing an APP mutant lacking both the Ab(1 ± 20) and C-terminal 31-residue regions (termed APPDAb20/ C31) and transfected it into COS-1 cells. The EthD-1 retention assay revealed that 32% of APPDC31-expressing cells were dead ( Figure 8B ). In this assay system, the cytotoxic level of APPDAb20/C31 was similar to those (*15% dead cells) of wild-type APP, b-Gal and APPDAb20, which showed only the non-specific viral cytotoxicity. These findings suggest that the Ab(1 ± 20) region of APPDC31 is indispensable for its cytotoxity.
Discussion
Caspase-3-independent apoptosis induced by APPDC31
Recent studies have demonstrated that APP is cleaved by caspases at Asp 664.
14 ± 16,18 ± 20, The present immunocytochemical study has shown that apoptotic neurons under serum-deprived conditions contained activated caspase-3 subunits and APPDC31 (Figure 1) . Furthermore, both APPDC31 and APP-C31 were detected in neurons overexpressing wild-type APP ( Figure 3A) . Generation of these fragments were significantly suppressed by treatment with caspase-3 inhibitor ( Figure 3B ). These findings suggest that overexpression of wild-type APP causes activation of caspases that subsequently cleave APP at the cytoplasmic Asp664 site (Figures 2A,B and 6B) . Intriguingly, APPDC31 per se caused apoptosis of neurons in a caspase-3-independent manner (Figures 5 and 6 ). We also found that overexpression of APPDC31 caused death of non-neuronal cells including proliferative neural precursor cells and transformed cell lines originating from non-neuronal tissues (Figures 7 and 8A) , indicating that the cytotoxic effects of APPDC31 are independent of cell species and their differentiation states. APP-C31, which is the counterpart of APPDC31 generated by caspase cleavage, has recently been reported to act as a cytotoxic peptide in cells treated with . APPDC31 is toxic to both NT2 stem cells and NT2 neurons (arrows), but only neurons undergo death by wild-type APP (arrowheads). Scale bar, 50 mm Figure 5 Caspase-3-independent neuronal death induced by APPDC31. NT2 neurons were infected with AxCAPDC31, fixed 72 h later, and analyzed for cell death (top panels) and DNA fragmentation (middle panels). Cells were labeled for the N-terminus of APP (P2-1), chromosomal DNA (Hoechst), and EthD-1 (EthD-1) (or TUNEL). Some of the APPDC31-accumulating neurons showing nuclear abnormalities are positively labeled with EthD-1 and TUNEL (arrows). Cells were also fixed 48 h after infection with AxCAPDC31 and stained for activated caspase-3 subunits (ACP3) (bottom panels). APPDC31-accumulating neurons have condensed nuclei, severe membrane blebbing, and dystrophic neurites, but are negative for activated caspase-3 (arrowheads). Scale bar, 50 mm for top and middle panels; 25 mm for bottom panels Cell Death and Differentiation APPDC31 mediates caspase-3-independent cell death I Nishimura et al apoptosis-inducing agents. 20 Thus, it is inferred that proteolytic processing of APP by caspases concomitantly generates APPDC31 and APP-C31 that exert their effects on cell death.
The molecular mechanisms whereby APPDC31 causes apoptotic cell death remain to be elucidated. Activated caspase-3 was undetected in neurons overexpressing APPDC31 (Figures 5 and 6B) . Furthermore, we were unable to detect the activation of other caspases such as caspases-7, -6, -8, and -9 or upregulation of the endoplasmic reticulum stress marker proteins such as Grp78 and GADD153 (I Nishimura and K Yoshikawa, unpublished observations). The APPDC31-induced cytotoxicity has previously been assessed using mouse neuroblastoma cells treated with the apoptosisinducing compounds staurosporine and tamoxifen. 20 APPDC31 had no cytotoxic effects on the neuroblastoma cells treated with staurosporine. However, they also reported that APPDC31 significantly reduced the cell viability when treated with tamoxifen. We have found that rodent cells require higher titers of APP-expressing adenoviruses than primate cells to undergo similar changes. We thus used primate cell lines infected with lower titers of adenovirus to demonstrate the cytotoxic effects of APP and APPDC31 in the present study. Thus we infer that cytotoxicity of APPDC31 is dependent on various factors such as cell types, APPDC31 expression levels, and presence of other cytotoxic agents.
In APP-overexpressing neurons, APP and subsequently generated APPDC31 would show additive or cooperative toxicity because they both have cytotoxic effects. However, we found that the neurotoxic potency of wild-type APP was similar to that of APPDC31 ( Figure 6A ). We used adenovirus titers that show a dead population of *30% among total infected cells, because higher titers exert nonspecific toxicity as generally observed in the adenovirus gene transfer system. Under these conditions, each infected neuron responds to APP with either death or survival. Thus, the fate of each APP-accumulating neuron cannot be changed even when cytotoxic APPDC31 is generated within the same cell. We speculate that this is the reason why wild-type APP (plus endogenously generated APPDC31) and APPDC31 showed similar cytotoxic potencies.
Some intracellular proteins have been reported to gain pathophysiological functions when cleaved by caspases. For example, Acinus and transcription factor NRF2 are cleaved by caspases and their cleaved products function as effectors for apoptosis. 21, 22 Furthermore, tau, a microtubule-associated protein whose abnormal phosphorylation is thought to cause formation of neurofibrillary tangles seen in AD, is cleaved by caspase-3 in vitro, and overexpression of the caspase-cleaved N-terminal fragment of tau induces apoptosis of NT2 stem cells and COS cells. 23, 24 These Neuronal specificity of caspase-mediated apoptosis induced by wild-type APP
Overexpression of wild-type APP causes caspase-3-mediated apoptosis of postmitotic neurons but not of nonneuronal cells, 11 suggesting that a neuron-specific machinery is involved in APP-induced caspase-3 activation. It has been demonstrated that two adaptor proteins, mammalian Disabled and FE65, which are primarily expressed in neurons, interact with the cytoplasmic tail of APP that contains the adaptor protein-binding motif NPTY. 25 This suggests that APP acts as a neuronal surface receptor that mediates intracellular signal transduction. Thus, APP-binding adaptor proteins such as Disabled and FE65 may contribute to the neuronal specificity of APP-induced caspase-3 activation. This idea is supported by the present findings that APPDC31, which lacks the adaptor-binding C31 region, failed to activate caspase-3 ( Figures 5 and 6B ). Another possibility is that neuron-specific ion channels or neurotransmitter receptors are involved in APP-induced neuronal apoptosis. We have previously reported that wild-type APP increases glutamate-induced Ca 2+ influx into neuronal cytoplasm. 26 Furthermore, we have recently found that APP causes elevation of intracellular Ca 2+ levels in postmitotic neurons prior to caspase-3 activation (manuscript in preparation). These findings suggest that Ca 2+ channels or molecules regulating Ca 2+ channel activities are involved in caspase-3 activation caused by wild-type APP.
Transgenic mice carrying APP mutants such as APP (Val717Phe) 27 and APP695 (Lys670Asn/Met671Leu) 28 have been reported to show neuropathological changes accompanied by extracellular Ab depositions. However, no overt neuronal loss is detected in the brain regions in which Ab is extensively deposited in APP (Val717Phe) transgenic mice, 29 suggesting that extracellular Ab deposits per se are not toxic to neurons. The APP mutants in the transgenic mice in vivo may not be accumulated to toxic levels within neurons, whereas adenovirus-mediated overexpression of wild-type APP in vivo and in vitro induces a rapid elevation of APP levels sufficient for neuronal caspase-3 activation.
10,11
Self-association of APP may be responsible for caspase-3 activation It is noteworthy that the APP mutant lacking the Ab(1 ± 20) domain (APPDAb20), like APPDC31, induced no neuronal caspase-3 activation (Figures 2A,B and 6B ). These findings suggest that both the Ab domain and the cytoplasmic C31 region are indispensable for caspase-3 activation. We have previously reported that a C-terminal 100 amino acid fragment of APP, termed APP-C100, forms amyloid fibril-like structures in cDNA-transfected COS cells. 17 APP-C100 which encompasses the Ab and cytoplasmic C31 regions, is neurotoxic in vitro and in vivo.
5 Thus, we speculate the self-associating nature of the C-terminal region of APP is responsible for the caspase-3 activation and neuronal death. The cross-linking experiment revealed that wild-type APP-overexpressing neurons contained the *220 kDa APP-immunoreactive band ( Figure 4C ), suggesting that wild-type APP, which comprises intact APP-C100 region, is prone to self-associate to form homodimer when accumulated on the membrane. It has recently been reported that antibodies against subsequences of the extracellular APP domain induce neuronal apoptosis. 30, 31 A monoclonal antibody (22C11) against the extracellular APP66±81 region induces caspase-3 activation and apoptosis in neurons, suggesting that the antibody facilitates APP dimerization and activates the caspase pathway. 30 Furthermore, we confirmed that antibody 22C11 induced caspase-3 activation and apoptosis in NT2 neurons within 24 h (I Nishimura and K Yoshikawa, unpublished observations). These findings together suggest that self-association of APP on the cell surface triggers the caspase cascade in neuronal cytoplasm.
Pathophysiological implications of APP-induced neuronal death
Based on the present findings, we schematized our hypothesis for APP-induced events operative in postmitotic neurons ( Figure 9 ). Earlier studies have revealed that pathological stimuli and trophic factor deprivation upregulate endogenous APP levels.
14,32,33 Furthermore, histopathological studies have revealed that neurons in AD brain contain abnormally dense APP-immunoreactive materials. 34 ± 36 Thus, neurons may have a propensity to accumulate APP in response to various insults ranging from trophic factor deprivation to neurotoxic stimuli. This phenomenon can be a compensatory response of stressed neurons to protect themselves against degeneration because cell-associated APP possesses neuroprotective functions. 7, 8 When the amounts of APP accumulations in affected neurons reach abnormally high levels, APP may in turn start to self-associate and activate caspases. Neuron-specific machinery including intracellular signal transduction molecules, ion channels, or neurotransmitter receptors may be involved in caspase activation. The caspase-cleaved transmembrane fragment APPDC31 may facilitate neuronal death in cooperation with other caspase-cleavable death effectors. The present findings that APPDAb20 and APPDAb20/C31, both of which lack the Ab(1 ± 20) region, failed to induce appreciable cell death lead to the speculation that the Ab(1 ± 20) region is indispensable for apoptosis by both caspase-dependent and -independent pathways. It might be of particular interest to examine whether such events are actually operative in neurons that are eliminated during nervous system development and under neurodegenerative conditions such as AD.
Materials and Methods
Recombinant adenoviruses
Recombinant adenoviruses expressing wild-type APP and its mutants were constructed as previously. 10, 11 Sequences encoding APP mutants were synthesized by polymerase chain reaction (PCR)-mediated template modification. PCR was performed using primers carrying mutated sequences and restriction site (BglII, SalI) at the ends and human full-length APP695 cDNA as a template. 6, 37 To construct cDNA of Ab(1 ± 20)-lacking APP (APPDAb20), a PCR product lacking Ab(1 ± 20) region was inserted between BglII and SalI sites of APP695 cDNA. To construct APPDC31, a sequence corresponding APP (amino acids 576 ± 664) was amplified by PCR with a primer that carries two stop codons at the 3' end and inserted in APP cDNA. APPDAb20 and APPDcC31 DNAs were fully sequenced, blunt-ended, and subcloned at the SwaI site of pAxCAwt. Cosmid DNA was cotransfected with the EcoT221-digested DNA-terminal protein complex of Ad5-dlX into 293 cells to generate recombinant viruses by homologous recombination. Adenovirus vectors expressing wild-type APP, APPDAb20, and APPDC31 were designated as AxCAYAP, AxCAPDAb20, and AxCAPDC31, respectively. Adenovirus expressing b-galactosidase (b-Gal) (AxCALacZ) was provided by Dr. I Saito (University of Tokyo, Tokyo, Japan). Propagation, and titration of recombinant adenoviruses were performed as described previously. 10, 11 Experiments using recombinant adenoviruses were approved by the Recombinant DNA Committee of the Osaka University and performed according to the institutional guidelines.
Adenovirus infection into cultured cells
Human embryonal carcinoma cells of NTera2/cl.D1 (NT2) cell line 38 (Stratagene, La Jolla, CA, USA) were cultured and neurally differentiated as reported previously. 11, 39 Briefly, NT2 cells were treated with 10 mM all-trans retinoic acid (Sigma, St. Louis, MO, USA) for 30 days and subcultured at *3.0610 5 cells per 35 mm dish at 378C and 5% CO 2 in the medium Opti-MEM (Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal calf serum (FCS) containing 1 mM cytosine arabinoside (Sigma) to obtain enriched postmitotic neurons. Serum-deprived neuronal cultures were obtained by incubating neurons in the absence of FCS for 96 h. COS-1 cells, human Bu17 glioma cells, and HeLa cells were cultured in the medium Dulbecco's modified Eagle medium supplemented with 10% FCS. NT2 neurons and other cells were exposed to recombinant adenovirus vectors at 2610 7 pfu/ml culture medium for 12 h (multiplicity of infection 25 ± 50) and then incubated in a virus-free fresh medium up to 96 h.
11
Antibodies
End-specific antibodies against activated caspase-3 p20/p17 subunits (ACP3), APPDC31 (SAC), and APP-C31 (ACT1) were raised in rabbits against synthetic peptides corresponding to the caspase-3 cleavage site, 40 APP 658±664 of APP695, 15 APP 665 ± 670 of APP695, respectively. Immunoglobulins G (IgGs) of SAC and ACT1 were depleted of IgG recognizing a bridging peptide corresponding to APP (amino acids 657 ± 670) that spans the caspase cleavage site by affinity chromatography (ProtOn Kit1, Multiple Peptide Systems, San Diego, CA, USA). End-specific reactivities of the antibodies ACP3, SAC, and ACT1 were confirmed by ELISA titration, Western blotting analysis, and immunocytochemistry. Other antibodies used are: a mouse monoclonal antibody against MAP2 (Chemicon, Temecula, CA, USA); a rabbit polyclonal antibody against b-Gal (Cappel, Aurora, OH, USA); a mouse monoclonal antibody P2-1 against the Nterminus of APP 41 (a gift from Dr. Van Nostrand); a rabbit polyclonal antibody against APP (amino acids 671 ± 695) (AC1); 6 a rabbit polyclonal antibody against APP (amino acids 18 ± 38) (AN2).
Immunocytochemistry
NT2 neurons and other cells grown on coverslips were fixed 48 ± 72 h after adenovirus infections with 4% formaldehyde in phosphatebuffered saline (PBS) (pH 7.4) at 48C for 20 min and permeabilized with acetone at 7208C for 20 min. Then, fixed cells were incubated with primary antibodies in PBS containing 0.05% Tween 20 at 48C overnight. The cells were then incubated at room temperature for 1 h with anti-rabbit and anti-mouse IgGs conjugated with fluorescein isothiocyanate (FITC) or rhodamine (Cappel). For chromosomal DNA staining, cells were incubated with 5 mM Hoechst 33342 (Sigma) in PBS at room temperature for 10 min. Nuclear DNA fragmentation was analyzed by the TUNEL method. 42 combined with immunostaining for APP with P2-1. TUNEL reactivity and APP were visualized with Texas Red and FITC, respectively. For caspase-3 inhibitor protection analysis, NT2 neurons were preincubated for 1 h with DMSO vehicle or Z-DEVD-FMK (Caspase-3 Inhibitor II; Calbiochem, La Jolla, CA, USA), infected with adenoviruses, and cultured for 72 h. After fixation, NT2 neurons were immunostained for APPDC31 with SAC and for APP-C31 with ACT1. Immunoreactive images were observed by fluorescence microscopy (BX50-34-FLAD1, Olympus, Tokyo, Japan).
Cell death analysis
NT2 neurons and other cells were infected with adenoviruses, and 48 h or 72 h later the cells were incubated with 10 mM EthD-1 (Molecular Probes, Eugene, OR, USA) in PBS at 378C for 30 min. After fixation, the cells were incubated with the antibody P2-1 against the Nterminus of APP and anti-b-Gal antibody, and subsequently incubated with FITC-conjugated anti-mouse and anti-rabbit IgGs, respectively. EthD-1-positive cells among 100 ± 200 APP-and b-Gal-positive cells were counted by choosing five random fields per each dish and expressed as a percentage. Statistical significance was tested using Student's t-test.
Cross-linking of cell surface proteins NT2 neurons were infected with adenoviruses. The cells were washed 24 h later with a buffer containing 137 mM NaCl, 5.3 mM KCl, 170 mM Na 2 HPO 4 , 220 mM KH 2 PO 4 , 10 mM HEPES, (pH 7.3), 33 mM glucose, and 44 mM sucrose and incubated with 1 mg/ml bis (sulfosuccinimidyl) suberate (Pierce, Rockford, IL, USA) in the buffer for 30 min at 378C. After cross-linking, neurons were harvested, and their lysates were analyzed by Western blot analysis.
Western blot analysis
NT2 neurons infected with adenovirus were dislodged by pipetting the medium up and down with a Pasteur pipette several times. Most of the non-neuronal cells remained attached after this treatment. Detached neurons were then collected by centrifugation at 1206g for 5 min. Enriched neurons were resuspended in the buffer containing 10 mM Tris-HCl, pH 7.4, 100 mM phenylmethanesulfonyl fluoride, 10 mM pepstatin, 10 mM leupeptin, and 2 mg/ml aprotinin. The homogenates were centrifuged at 15 0006g for 30 min, and proteins (2 mg per lane) in the pellets (membrane fraction) were separated by 7.5% SDSpolyacrylamide gel electrophoresis. For analysis of cross-linked cell extracts, 2 mg proteins were separated by 6% SDS-polyacrylamide gel electrophoresis. Proteins were transferred to polyvinylidene difluoride membrane (Millipore, Bedford, MA, USA), and blotted with AC1, AN2, and SAC. The membrane was incubated with peroxidase-labeled antirabbit IgG, and the signals were detected with chemiluminescence reagents (Renaissance Plus; NEN, Boston, MA, USA).
Measurement of caspase-3-like protease activity
Adenovirus-infected NT2 neurons were collected and incubated on ice for 10 min in a cell lysis buffer for caspase activity assay (MBL, Nagoya, Japan). Lysates were centrifuged at 15 0006g for 10 min at 48C, and the supernatant (10 mg protein) was used for caspase-3-like protease assay. Caspase-3-like activity was measured by cleavage of the fluorogenic substrate Z-DEVD-AFC using a kit (FluorAce Apopain kit; Bio-Rad, Hercules, CA, USA) and a spectrofluorometer (VersaFluor; Bio-Rad). One unit was defined as the amount of enzyme required to cleave 1 pmol AFC per 60 min incubation at 378C.
COS-1 cytotoxic assay
cDNA encoding an APP mutant lacking both the Ab(1 ± 20) and the Cterminal 31-residue regions (APPDAb20/C31) was constructed by PCR using primers for APPDC31 and APPDAb20 cDNAs as described above. b-Gal, wild-type APP, APPDAb20, APPDC31, and APPDAb20/ C31 cDNAs were subcloned into pcDNA3.1(+) carrying the cytomegalovirus promoter (Invitrogen, San Diego, CA, USA). Vectors expressing APPs and b-Gal (1 mg per assay) were introduced into COS-1 cells using Lipofectamine Plus (Gibco, Gaithersburg, MD, USA), and cell death was analyzed at 72 h as above.
